Background and Purpose: Fiberoptic endoscopic evaluation of swallowing (FEES) is a suitable method for dysphagia assessment after acute stroke. Recently, we developed the fiberoptic endoscopic dysphagia severity scale (FEDSS) for acute stroke patients, grading dysphagia into 6 severity codes (1 to 6; 1 being best). The purpose of this study was to investigate the impact of the FEDSS as a predictor of outcomes at 3 months and intermediate complications during acute treatment. Methods: A total of 153 consecutive first-ever acute stroke patients were enrolled. Dysphagia was classified according to the FEDSS, assessed within 24 h after admission. Intermediate outcomes were pneumonia and endotracheal intubation. Functional outcome was measured by the modified Rankin Scale (mRS) at 3 months. Multivariate regression analysis was used to identify whether the FEDSS was an independent predictor of outcome and intercurrent complications. Analyses were adjusted for sex, age and National Institutes of Health Stroke Scale (NIH-SS) on admission. Results: The FEDSS was found to predict the mRS at 3 months as well as but independent from the NIH-SS. For each additional point on the FEDSS, the likelihood of dependency at 3 months (mRS ≥ 3) raised by ∼50%. Each increase of 1 point on the FEDSS conferred a more than 2-fold increased chance of developing pneumonia. The odds for the necessity of endotracheal intubation raised by a factor of nearly 2.5 with each additional point on the FEDSS. Conclusions: The FEDSS strongly and independently predicts outcome and intercurrent complications after acute stroke. Thus, a baseline FEES examination provides valuable prognostic information for the treatment of acute stroke patients.

Keywords:
Acute stroke, Dysphagia, Swallowing, Fiberoptic endoscopic evaluation of swallowing
1.
Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R: Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005;36:2756–2763.
2.
Smithard DG, Smeeton NC, Wolfe CD: Long-term outcome after stroke: does dysphagia matter? Age Ageing 2007;36:90–94.
3.
Smithard DG, O’Neill PA, Park C, Morris J, Wyatt R, England R, Martin DF: Complications and outcome after acute stroke – does dysphagia matter? Stroke 1996;27:1200–1204.
4.
Walter U, Knoblich R, Steinhagen V, Donat M, Benecke R, Kloth A: Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol 2007;254:1323–1329.
5.
Dziewas R, Ritter M, Schilling M, Konrad C, Oelenberg S, Nabavi DG, Stögbauer F, Ringelstein EB, Lüdemann P: Pneumonia in acute stroke patients fed by nasogastric tubes. J Neurol Neurosurg Psychiatry 2004;75:852–856.
6.
Ramsey DJC, Smithard DG, Kalra L: Early assessments of dysphagia and aspiration risk in acute stroke patients. Stroke 2003;34:1252–1257.
7.
Mann G, Hankey GJ, Cameron D: Swallowing function after stroke: prognosis and prognostic factors at 6 month. Stroke 1999;30:744–748.
8.
Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S: Formal dysphagia screening protocols prevent pneumonia. Stroke 2005;36:1972–1976.
9.
Foley N, Teasell R, Salter K, Kruger E, Martino R: Dysphagia treatment post stroke: a systematic review of randomised controlled trials. Age Ageing 2008;37:258–264.
10.
Carnaby G, Hankey GJ, Pizzi J: Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol 2006;5:31–37.
11.
Warnecke T, Teismann I, Meimann W, Olenberg S, Zimmermann J, Kramer C, Ringelstein EB, Schabitz WR, Dziewas R: Assessment of aspiration risk in acute ischaemic stroke – evaluation of the simple swallowing provocation test. J Neurol Neurosurg Psychiatry 2008;79:312–314.
12.
Trapl M, Enderle P, Nowotny M, Teuschl Y, Matz K, Dachenhausen A, Brainin M: Dysphagia bedside screening for acute-stroke patients: the Gugging Swallowing Screen. Stroke 2007;38:2948–2952.
13.
Warnecke T, Teismann I, Oelenberg S, Hamacher C, Ringelstein EB, Schabitz WR, Dziewas R: The safety of fiberoptic endoscopic evaluation of swallowing in acute stroke patients. Stroke 2009;40:482–486.
14.
Dziewas R, Warnecke T, Olenberg S, Teismann I, Zimmermann J, Kramer C, Ritter M, Ringelstein EB, Schabitz WR: Towards a basic endoscopic assessment of swallowing in acute stroke – development and evaluation of a simple dysphagia score. Cerebrovasc Dis 2008;26:41–47.
15.
Warnecke T, Dziewas R, Oelenberg S, Ritter M, Dittrich R, Schäbitz WR, Ringelstein EB, Nabavi DG: Serial fiberoptic examination of swallowing in patients with acute stroke and dysphagia: case report and general considerations. J Stroke Cerebrovasc Dis 2006;15:172–175.
16.
Langmore SE: Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? Curr Opin Otolaryngol Head Neck Surg 2003;11:485–489.
17.
Leder SB, Espinosa JF: Aspiration risk after acute stroke: comparison of clinical examination and fiberoptic endoscopic evaluation of swallowing. Dysphagia 2002;17:214–218.
18.
Lim SHB, Lieu PK, Phua SY, Seshadri R, Venketasubramanian N, Lee SH, Choo PWJ: Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia 2001;16:1–6.
19.
Warnecke T, Teismann I, Oelenberg S, Hamacher C, Ringelstein EB, Schabitz WR, Dziewas R: Towards a basic endoscopic evaluation of swallowing in acute stroke – identification of salient findings by the inexperienced examiner. BMC Med Educ 2009;9:13.
20.
Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864–870.
21.
Guijar AR, Deibert E, Manno EM, Duff S, Diringer MN: Mechanical ventilation for ischemic stroke and intracranial hemorrhage: indications, timing and outcome. Neurology 1998;51:447–451.
22.
Berger K, Weltermann B, Kolominsky-Rabas P, Meves S, Heuschmann P, Bohner J, Neundorfer B, Hense HW, Buttner T: [The reliability of stroke scales. The German version of NIHSS, ESS and Rankin scales]. Fortschr Neurol Psychiatr 1999;67:81–93.
23.
Wade DT: Rankin Scale. Oxford, Oxford University Press, 1992, pp 238–239.
24.
Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD: Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126–131.
25.
Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D: Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003;34:1114–1119.
26.
Sellars C, Bowie L, Bagg J, Sweeney MP, Miller H, Tilston J, Langhorne P, Stott DJ: Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007;38:2284–2291.
27.
Upadya A, Thorevska N, Sena KN, Manthous C, Amoateng-Adjepong Y: Predictors and consequences of pneumonia in critically ill patients with stroke. J Crit Care 2004;19:16–22.
28.
Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR: Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 2004;11:49–53.
29.
Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD: Nosocomial pneumonia after acute stroke – implications for neurological intensive care medicine. Stroke 2003;34:975–981.
30.
Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW: The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003;60:620–625.
31.
Holloway RG, Benesch CG, Burgin WS, Zentner JB: Prognosis and decision making in severe stroke. JAMA 2005;294:725–733.
32.
Murray J, Langmore SE, Ginsberg S, Dostie A: The significance of accumulated oropharyngeal secretions and swallowing frequency in predicting aspiration. Dysphagia 1996;11:99–103.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.